Stimulation/NN
of/IN
human/JJ
lymphocyte/NN
proliferation/NN
and/CC
CD40/NN
antigen/NN
expression/NN
by/IN
phosphorothioate/NN
oligonucleotides/NNS
complementary/JJ
to/TO
hepatitis/NN
B/NN
virus/NN
genome/NN
./.

We/PRP
have/VBP
studied/VBN
the/DT
proliferation/NN
and/CC
CD40/NN
antigen/NN
expression/NN
of/IN
lymphocytes/NNS
,/,
and/CC
the/DT
cytotoxicity/NN
to/TO
monocytes/NNS
,/,
of/IN
antisense/JJ
phosphorothioate/NN
oligodeoxynucleotides/NNS
complementary/JJ
to/TO
the/DT
SP/NN
II/CD
promoter/NN
of/IN
HBV/NN
mRNA/NN
(/(
sequence/NN
I/NN
)/)
and/CC
the/DT
X/NN
gene/NN
(/(
sequence/NN
II/CD
)/)
in/IN
patients/NNS
with/IN
chronic/JJ
hepatitis/NN
B/NN
./.
=====
The/DT
oligo/JJ
sequence/NN
I/NN
stimulated/VBD
proliferation/NN
of/IN
both/CC
T/NN
and/CC
,/,
to/TO
a/DT
lesser/JJR
extent/NN
,/,
B/NN
cells/NNS
./.
=====
The/DT
percentage/NN
of/IN
cells/NNS
expressing/VBG
CD40/NN
in/IN
T/NN
and/CC
B/NN
cell/NN
co-cultures/NNS
increased/VBD
from/IN
4.2/CD
%/NN
to/TO
13.8/CD
%/NN
after/IN
oligo/JJ
stimulation/NN
in/IN
patients/NNS
,/,
while/IN
it/PRP
increased/VBD
form/NN
4.7/CD
%/NN
to/TO
48.6/CD
%/NN
in/IN
healthy/JJ
controls/NNS
./.
=====
The/DT
sense/NN
sequence/NN
(/(
sequence/NN
III/CD
)/)
of/IN
the/DT
X/NN
gene/NN
also/RB
enhanced/VBD
the/DT
expression/NN
of/IN
CD40/NN
antigen/NN
in/IN
patients/NNS
with/IN
hepatitis/NN
B/NN
./.
=====
The/DT
proportion/NN
of/IN
CD40/NN
cells/NNS
(/(
26/CD
%/NN
)/)
in/IN
a/DT
resting/VBG
B-cell/NN
preparation/NN
from/IN
hepatitis/NN
B/NN
patients/NNS
decreased/VBD
to/TO
zero/CD
after/IN
a/DT
5-day/JJ
culture/NN
with/IN
sequence/NN
I/NN
,/,
but/CC
IgG/NN
levels/NNS
in/IN
the/DT
culture/NN
supernatant/NN
increased/VBD
./.
=====
The/DT
cytotoxic/JJ
properties/NNS
of/IN
monocytes/NNS
were/VBD
not/RB
influenced/VBN
by/IN
the/DT
oligos/NNS
./.
=====
These/DT
findings/NNS
indicate/VBP
that/IN
antisense/JJ
oligos/NNS
against/IN
hepatitis/NN
B/NN
virus/NN
(/(
HBV/NN
)/)
have/VBP
mitogenic/JJ
effects/NNS
on/IN
the/DT
proliferation/NN
of/IN
human/JJ
lymphocytes/NNS
in/IN
a/DT
non-specific/JJ
manner/NN
and/CC
may/MD
activate/VB
T/NN
cells/NNS
to/TO
express/VB
CD40/NN
antigen/NN
./.